Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 5Psoriasis 4Lymphoma, Follicular 2Leukemia, Myelomonocytic, Juvenile 2Wilms Tumor 1Stomatitis 1Spondylitis, Ankylosing 1Respiratory Distress Syndrome 1Recurrence 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Plaque, Amyloid 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Melanoma 1Lupus Nephritis 1Lung Injury 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Inflammation 1Diabetes Mellitus, Type 1 1Dermatomyositis 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Bronchiolitis Obliterans Syndrome 1Bronchiolitis Obliterans 1Blast Crisis 1

Interventions

Adalimumab 2tocilizumab 1Vaccines 1Saline Solution 1Herpes Zoster Vaccine 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Spondylitis, Ankylosing × Etanercept × Clear all
NCT01060098 2020-01-18

T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

Imperial College London

Completed
48 enrolled 6 charts

Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡